Dengfeng Cao, MD, PhD

Professor, Pathology & Immunology
Section Head, Genitourinary Pathology

Education

  • MD: Peking Union Medical College, Beijing, China (1996)
  • PhD: University of Pittsburgh, Pittsburgh, Pennsylvania (2001)
  • Residency, Anatomic and Clinical Pathology: The Johns Hopkins Hospital, Baltimore, Maryland (2005)
  • Fellowship, Surgical Pathology: The Johns Hopkins Hospital, Baltimore, Maryland (2006)
  • Fellowship, Gynecologic Pathology: The Johns Hopkins Hospital, Baltimore, Maryland (2007)

Board Certifications

  • Anatomic and Clinical Pathology, American Board of Pathology, 2005
  • 2007 to present: Missouri Medical License
  • 2015 to present: Michigan Medical License
  • 2015 to present: Illinois Medical License

Recognition

  • The Joseph C. Eggleston Award for Excellence in Surgical Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, 2004
  • Young Investigator Award, Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, 2004
  • Young Investigator Award, Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, 2007
  • Faculty Teacher of the Year, Department of Pathology, Washington University School of Medicine, 2017-2018

Clinical Interests

  • Gynecologic Pathology
  • Genitourinary Pathology
  • General Surgical Pathology

Research Interests

Gynecologic pathology, genitourinary pathology, pancreatic pathology

Editorial Responsibilities

2008 – Present Editorial board member International Journal of Clinical and Experimental Pathology

Service to the Department

2015 – Present Surgical Pathology
2007 – 2012 Director, Research Immunohistochemistry Lab

Publications

PubMed Search

Yang C, Sun Li, Zhang L, Zhou L, Zhao M, Peng Y, Niu D, Li Z, Huang X, Kang Q, Jia L, Lai J, Cao D. Diagnostic utility of SATB2 in metastatic Krukenberg tumors of the ovary: an immunohistochemical study of 70 cases with comparison to CDX2, CK7, CK20, chromogranin and synaptophysin. Am J Surg Pathol. 2018;42(2):160-171
 Humphrey PA, Amin MB, Berney DM, Billis A, Cao D, Cheng L, Delahunt B, Egevad L, Epstein JI, Fine SW, Grignon DJ, Kristiansen G, Lopez-Beltran A, Magi-Galluci C, Netto GJ,       Rubin MA, Samaratuga H, Srigley JR,       True LD, Tsuzuki T, Van Der Kwast T. Acinar Adenocarcinoma. Moch H, Humphrey PA, Ulbright TM, Reuter V. (Eds): WHO Classification of Tumours of the Urinary System and Male Genital Organs. (4th edition). IARC Press: Lyon 2016; 138-162.
 Prat J, Cao D, Carinelli SG, Nogles FF, Vang R, Zaloudek CJ. Germ Cell Tumours. Kurman RJ, Carcangiu ML, Herrington CS, Young RH. (Eds): WHO Classification of Tumours of Female Reproductive Organs. (4th edition). IARC Press: Lyon 2014; 57-62.
 Liu T, Hamilton N, Hawkins W, Gao F, Cao D. Comparison of WHO Classifications (2004, 2010), the Hochwald Grading System, and AJCC and ENETS Staging Systems in Predicting Prognosis in Locoregional Well-differentiated Pancreatic Neuroendocrine Tumors. Am J Surg Pathol. 2013;37(6):853-9.
 Kunkel J, Peng Y, Tao Y, Krigman H, Cao D. Presence of sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian mixed mesodermal tumor: a clinicopathologic study of 47 cases. Am J Surg Pathol. 2012; 36(6):831-7.
Cao D, Liu A, Wang F, Allan RW, Mei K, Peng Y, Du J, Guo S, Abel TW, Lane Z, Ma J, Rodriguez M, Akhi S, Dahiya N, Li J. RNA-binding protein Lin28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases. Mod Pathol. 2011; 24(2):288-96.
 Cao D, Kibel AS, Gao F, Tao Y, Humphrey PA. The Gleason score of tumor at the margin in radical prostatectomy is predictive of biochemical recurrence. Am J Surg Pathol. 2010; 34(7):994-1001.
 Liu A, Cheng L, Du J, Peng Y, Allan RW, Wei L, Li J, Cao D. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am J Surg Pathol. 2010; 34(5):697-706.
 Cao D, Li J, Guo CC, Allan RW, Humphrey PA. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol. 2009; 33: 1065-1077.  
 Cao D, Guo S, Allan RW, Molberg KH, Peng Y. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009; 3(6): 894-904.

Assistant
Kathy Nesser
314-362-0154
knesser@wustl.edu

Office Location: BJC-IH Building, Room 3437